Project Grant R01CA291880
Award Date
4/1/25
Completion Date
3/31/30
Dollars Obligated
$554K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $666,670 to the University of Pennsylvania to develop advanced scan protocols that combine long-axial-field-of-view positron emission tomography (PET) and spectral computed tomography (CT) imaging for improved quantification in oncology.
The primary goals are to: 1) Develop spectral CT protocols and processing pipelines to generate dynamic iodine maps and...
The National Cancer Institute (NCI) awarded a 5-year, $644,034 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a nanoparticle-based platform for radiation-activated drug delivery to improve chemoradiation therapy for certain hard-to-treat cancers. The project aims to optimize a "scintillating nanoparticle drug depot" (SCIDD) platform that uses X-ray...
This $549,536 Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) aims to develop a comprehensive 3D wearable near-infrared spectral tomography (NIRST) system to enhance early prediction of residual cancer burden in breast cancer patients undergoing neoadjuvant chemotherapy. The primary objectives are to integrate flexible circuit strips into a sleek, wearable 64-channel breast interface and apply advanced 3D image reconstruction...
The Trustees of the Colorado School of Mines received a three-year, $418,826 Project Grant from the National Cancer Institute, a division of the Department of Health and Human Services. The grant falls under the Cancer Detection and Diagnosis Research program (CFDA 93.394), which aims to improve cancer screening, early detection, and diagnostic techniques.
Under this award, the Colorado School of Mines will develop novel porous biomaterials containing immobilized metal catalysts and enzymes...
The National Cancer Institute (NCI) awarded a $673,366 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to the University of Chicago for the development of a novel X-ray dual-energy cone-beam microCT (DECB-microCT) imaging system to enhance intraoperative identification of positive margins in breast-conserving surgery. The key objectives are to: (1) develop the DECB-microCT system for quantitative lumpectomy specimen imaging; (2) acquire highly-sampled...
This federal Project Grant award of $490,381, provided by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), aims to develop nano-scale phase-changing contrast agents that enable continuous and high-fidelity ultrasound (US) imaging of immune cells in deep tissues. The key objectives are to: 1) Improve the consistency, power, and duration of the contrast agents' Doppler twinkling effect to enhance imaging resolution and cell localization; 2) Demonstrate the...
The National Cancer Institute awarded a $407,113 Project Grant (CFDA 93.396 - Cancer Biology Research) to Trustees of Boston University for the development of bio-orthogonal mid-infrared photothermal imaging technology to study cancer metabolism. This 3-year award, running from September 1, 2024 to August 31, 2027, aims to: 1) build a library of nitrile-based probes to sense molecular events in cancer cells; 2) develop nitrile-tagged small molecules to measure nutrient metabolism; and 3)...
This National Cancer Institute (NCI) Project Grant award under CFDA 93.394 (Cancer Detection and Diagnosis Research) provides $411,143 to the University of Illinois to develop a macrophage-based technology for targeted delivery of YAP/TEAD-inhibiting drugs to brain metastases in breast cancer patients. The key products or services to be delivered include:
Development and optimization of a Macrophage-Enabled Brain Metastasis Targeting (MEMT) system that can deliver nanoparticles carrying YAP...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $519,210 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program to the Regents of the University of Michigan. The project aims to develop nanoparticle (NP) strategies to program circulating monocytes and neutrophils in order to disrupt the metastatic niche and enhance anti-tumor immune responses in triple-negative breast cancer. Specific...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $483,556 to the University of New Mexico Health Sciences Center to conduct research on a novel nanoparticle-based immunotherapy for treating peritoneal metastases associated with ovarian and colorectal cancers. The research aims to define the mechanisms by which intraperitoneal delivery of toll-like receptor agonist-modified mesoporous silica nanoparticles can eliminate disseminated...